2025 fourth_quarter Filing
4TLobbying Activities
Issues related to potential tariffs on generic drugs.
Issues S. 43, Skinny Labels, Big Savings Act.
- Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues related to drug pricing including drug negotiation. - Issues related to Inflation Reduction Act. - Issues related to biosimilars. - Issues related to drug shortages.